Abstract
Colorectal adenocarcinoma is a leading cause of cancer-related death in the United States, accounting for more than estimated 50,000 deaths in each year [1]. Approximately two thirds of patients present with potentially curable disease. This group of patients undergoes surgical resection with or without adjuvant treatment (chemotherapy with or without radiation).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin. 2010;60:277–300.
Guyot F, Faivre J, Manfredi S, et al. Time trends in the treatment and survival of recurrences from colorectal cancer. Ann Oncol. 2005;16:756–61.
Tomlinson JS, Jarnagin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575–80.
Schoemaker D, Black R, Giles L, Toouli J. Yearly colonoscopy, liver CT and chest radiography do not influence 5-year survical of colorectal cancer patients. Gastroenterology. 1998;114:7–14.
Pietra N, Sarli L, Costi R, Ouchemi C, Grattarola M, Peracchia A. Role of follow-up in management of local recurrences of colorectal cancer: a prospective, randomized trial. Dis Colon Rectum. 1998;41:1127–33.
Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. A prospective randomized study of follow-up after radical surgery for colorectal cancer. Br J Surg. 1997;84:666–9.
Ohlsson B, Breland U, Ekberg H, et al. Follow-up after curative surgery for colorectal carcinoma: randomized comparison with no follow-up. Dis Colon Rectum. 1995;38:619–26.
Makela JT, Laitinen SO, Kairaluoma MI. Five-year follow-up after radical surgery for colorectal cancer: results of a prospective randomized trial. Arch Surg. 1995;130:1062–7.
Secco GB, Fardelli R, Gianquinto D, et al. Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial. Eur J Surg Oncol. 2002;28:418–23.
Ovaska J, Jarvinen H, Kujari H, Pertilla I, Mecklin JP. Follow-up of patients operated on for colorectal carcinoma. Am J Surg. 1990;159:593–6.
Rodriguez-Moranta F, Salo J, Arcusa A, et al. Postoperative surveillance in patients with colorectal cancer who have undergone curative resection: a prospective, multicenter, randomized, controlled trial. J Clin Oncol. 2006;24:386–93.
Figueredo A, Rumble RB, Maroun J, et al. Follow-up of patients with curatively resected colorectal cancer: a practice guideline. BMC Cancer. 2003;3:26.
Renehan AG, Egger M, Saunders MP, et al. Impact on survival of intense follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomized trials. BMJ. 2002;324:813.
Jeffery GM, Hickey BE, Hider P. Follow-up strategies for patients treated for non-metastatic colorectal cancer. Cochrane Database Syst Rev. 2002;1:CD002200.
NCCN colon cancer clinical practice guidelines in oncology. J Natl Compr Cancer Network. 2008;1:1–18.
Kjeldsen BJ, Kronborg O, Fenger C, Jorgensen OD. The pattern of recurrent colorectal cancer in a prospective randomized study and the characteristics of diagnostic tests. Int J Colorectal Dis. 1997;12:329–34.
Sargent D, Sobrero A, Grothey A, et al. Evidence for cure by adjuvant therapy in Colon Cancer: observations based on individual patient data from 20, 898 patients on 18 randomized trials. J Clin Oncol. 2009;6:872–7.
Gold P, Freedman SO. Demonstration of tumor-specific antigens in colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med. 1965;121:439–62.
Arnaud JP, Koehl C, Adloff M. Carcinoembryonic antigen (CEA) in the diagnosis and prognosis of colorectal carcinoma. Dis Colon Rectum. 1980;23:141–4.
Libutti SK, Alexander HR, Choyke P, et al. A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99 m Tc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing CEA levels. Ann Surg Oncol. 2001;8:779–86.
Tsikitis VL, Malireddy K, Green EA, et al. Postoperative recommendations for early stage colon cancer based on results from the clinical outcomes of surgical therapy trial. J Clin Oncol. 2009;22:3671–6.
Green RJ, Metlay JP, Propert K, et al. Surveillance for second primary colorectal cancer after adjuvant chemotherapy: an analysis of Intergroup 0089. Ann Intern Med. 2002;136:261–9.
Graffner H, Hultberg B, Johansson B, Moller T, Petersson BG. Detection of recurrent cancer of the colon and rectum. J Surg Oncol. 1985;28:156–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Humana Press
About this chapter
Cite this chapter
Tejani, M.A., Cohen, S.J. (2013). Colon and Rectum Carcinoma Surveillance Counterpoint: USA. In: Johnson, F., et al. Patient Surveillance After Cancer Treatment. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60327-969-7_33
Download citation
DOI: https://doi.org/10.1007/978-1-60327-969-7_33
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60327-968-0
Online ISBN: 978-1-60327-969-7
eBook Packages: MedicineMedicine (R0)